AzTrials
AzTrials

Early Childhood CariesPhase 2NCT06241261

Arresting Early Childhood Caries With a Silver Diamine Fluoride Gel

A Phase 2 study testing Silver diamine fluoride gel and Silver diamine fluoride solution in people with Early Childhood Caries, run by The University of Hong Kong at 1 site in China.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The objective is to determine whether the efficacy of a 38% silver diamine fluoride (SDF) gel is non-inferior to a 38% SDF solution for arresting carious lesions in preschool children when applied at half-yearly intervals over a 30-month period. Read more about this study

Who is it for?
Ages 3 to 5 yearsHealthy volunteers can take part
Conditions the study is for
Early Childhood Caries
What is being tested?
Silver diamine fluoride gel and Silver diamine fluoride solution
Could I receive a placebo?
No, everyone receives an active treatment
How many people
630 participants
Where
1 siteChina
Study dates
1 Jan 2024to 31 Dec 2027
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 5 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • generally healthy, have at least one tooth with cavitated dentine carious lesion

Who cannot join

  • uncooperative and difficult to manage, with severe forms of hypoplasia of fluorosis or other oral diseases, wearing orthodontic devices or under dental treatment, have major systemic diseases, or are on long-term medication

Trial locations and contacts

1 site in 1 country.

China1 site
  • The University of Hong Kong

    Hong Kong

Other trials in China

About this study

Official title: Randomised Clinical Trial to Arrest Early Childhood Caries With a Silver Diamine Fluoride Gel

The objective is to determine whether the efficacy of a 38% silver diamine fluoride (SDF) gel is non-inferior to a 38% SDF solution for arresting carious lesions in preschool children when applied at half-yearly intervals over a 30-month period.

Read the detailed description

Aim: Silver diamine fluoride (SDF) is typically available as a 38% aqueous solution, which is runny and difficult to apply. A 38% SDF gel has been introduced but it has not been tested clinically. The objective is to determine whether the efficacy of a 38% SDF gel is non-inferior to a 38% SDF solution for arresting carious lesions in preschool children.

Methods / Design: This non-inferiority randomised clinical trial will recruit 630 3- to 4-year-old children to receive either SDF gel or SDF solution on their carious lesions every 6 months. The primary outcome is the proportion of active carious tooth surfaces that arrest at the 30-month follow-up. The same examiner will conduct all examinations at the kindergartens over 30 months. The examiner, the children, and the children's parents will be blinded to treatments. The parents will be surveyed on their child's oral health-related behaviours and socioeconomic background to allow adjustment for effect modification.

Significance: If the result is as anticipated, SDF gel will prolong contact of SDF with the carious lesion to promote remineralisation. As SDF gel is cost-effective, simple, non-invasive, and non-aerosol-generating, it can be widely recommended for caries control.

Being tested
Silver diamine fluoride gel, Silver diamine fluoride solution
Keywords
Silver Diamine Fluoride, Caries, Arrest, Gel, Children
Medical subject headings
Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Silver diamine fluoride gelDrug

    Also called SDF gel

    Application of 38% SDF gel every 6 months

  • Silver diamine fluoride solutionDrug

    Also called SDF solution

    Application of 38% SDF solution every 6 months

Study groups in NCT06241261
Study groupRoleWhat they receive
Silver diamine fluoride gelExperimental38% silver diamine fluoride gel
Receives: Drug: Silver diamine fluoride gel
Silver diamine fluoride solutionActive comparator38% silver diamine fluoride solution
Receives: Drug: Silver diamine fluoride solution

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The hardness of cavity on tooth by probing

    The number of active carious tooth surfaces that become arrested per child

    Measured: The follow-up oral examinations will be conducted every 6 months for 30 months totally

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2024
  2. Study start1 Jan 2024
  3. Primary completion31 Aug 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
630 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06241261
Sponsor's protocol ID
UW 23-064
Status last verified
Mar 2026
First submitted
26 Jan 2024
Last updated
5 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Cheng AY, Chen J, Zheng FM, Duangthip D, Chu CH. Arresting Early Childhood Caries with Silver Diamine Fluoride Gel Among Preschool Children: Protocol for a Randomised Clinical Trial. Dent J (Basel). 2024 Dec 22;12(12):419. doi: 10.3390/dj12120419.

    PubMed 39727476

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Silver diamine fluoride gel and Silver diamine fluoride solution in people with Early Childhood Caries, run by The University of Hong Kong at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 5 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The hardness of cavity on tooth by probing (time frame: The follow-up oral examinations will be conducted every 6 months for 30 months totally). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06241261, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in